ASIC-Licensed Business & IP Valuations
Trusted experts in complex, innovation-driven sectors
Get a defensible, investment-grade valuation — tailored to your goals.
Why Clients Choose Sherwood for Valuations
At Sherwood Australia, we provide expert business and IP valuation services for companies at every stage of growth. We specialise in non-traditional and complex valuation scenarios—particularly where intellectual property, R&D assets, or early-stage innovation play a central role. Whether you're planning a capital raise, facing a commercial dispute, or preparing for a strategic transaction, our team brings deep sector knowledge and global transaction experience to deliver precise, defensible valuations that are insightful, strategic, and investment-grade.
IP Valuation Depth
Extensive experience valuing innovation-driven, IP-rich businesses across life sciences and tech.
Proven Transactions
Track record of capital raises, strategic deals, and dispute resolutions delivering real outcomes.
Specialist Methodologies
Leading expertise in rNPV and other advanced valuation techniques for early-stage and clinical assets.
Global Investor Lens
International perspective tailored to life sciences, backed by AFSL and local ecosystem integration.
AFSL-Licensed for Equity Valuations
ASIC requires an AFSL for any valuation involving company equity. Providers without an AFSL cannot legally perform equity valuations. Sherwood Australia holds AFSL 563351, giving you a compliant and reliable valuation.
Valuing the Unquantifiable
Early-stage and IP-rich company valuations are complex—but getting them right is critical. Our free guide explains how to navigate uncertainty, from rNPV to milestone-based modelling. Please leave your email address to receive Valuing the Unquantifiable: A Guide to Early-Stage and IP-Rich Company Valuations.
Industries We Serve
We’ve successfully delivered valuations across sectors where intangible assets, innovation, and future potential drive enterprise value. These include — but are not limited to:
-
Biotechnology
-
Medical Technology (MedTech)
-
Pharmaceuticals & Therapeutics
-
Diagnostics
-
Digital Health & HealthTech
-
Artificial Intelligence & Data-Driven Ventures
-
Software & SaaS
-
Advanced Manufacturing
-
Aerospace & Defence
-
Education & Training
-
Technology Commercialisation
From clinical-stage biotech firms and robotics-enabled surgical systems to AI-based diagnostics and SaaS platforms, Sherwood’s valuation expertise spans some of the world’s most dynamic and complex sectors.
Hear From Our Clients
Biotech – Shareholder Dispute Resolution
"Sherwood’s valuation work brought clarity and credibility at a critical moment. Their expert report helped resolve a long-standing shareholder dispute without the need for costly litigation. It was a game-changer."
— CEO, Clinical-Stage Biotech Company
MedTech – VC Negotiation Support
"The valuation prepared by Anthony and the Sherwood team gave us real leverage in our Series A discussions. It was robust, defensible, and tailored to the reality of early-stage MedTech — exactly what we needed to engage seriously with top-tier VCs."
— CFO, Surgical Device Company
Deep Tech / HealthTech – Hard-to-Value Business
"We approached multiple firms, but most wouldn’t touch our company due to its complexity. Sherwood not only took it on — they delivered a valuation that gave us a solid footing in debt negotiations and a clearer path forward with investors."
— Founder, AI-Driven HealthTech Platform
Valuations Tailored to Your Situation
We regularly deliver valuations to support a wide variety of client needs:
-
Capital Raising – Seed, Series A/B, and later-stage funding rounds
-
Business Sales & M&A – Full divestments, acquisitions, and exits
-
Strategic Partnerships & Licensing – IP valuation to support negotiation
-
Restructuring & Internal Reorganisations – Transfer pricing and IP allocations
-
Litigation & Dispute Resolution – Court-admissible valuation reports
-
Taxation & Compliance – ATO requirements, employee share schemes
-
Financial Reporting & Governance – Independent valuations for board use
-
Investment Decisions – Supporting inbound or outbound due diligence
Our track record
250+
company valuations
50+
company transactions advised
$500M+
transaction value
$5-$350M
deal size range
Need a Valuation?
We provide fast, professional valuation reports tailored to your needs and sector. Whether you're raising capital, entering a transaction, or simply want clarity on your company’s worth—talk to Sherwood.
Contact Anthony Vago today at anthony@sherwoodaustralia.com.au or +61 406 155 571 for a confidential discussion, or leave your details here and our valuations experts will get in touch with you within 24 hours.
A Proud Member of Sherwood Global Partners
As part of Sherwood Global Partners, we tap into a powerful international network of corporate finance experts, strategic partners, and investors — bringing global opportunity to every transaction.